Related Experiment Videos

Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging

Xiu-Fen Ming1, Jean-Pierre Montani, Zhihong Yang

  • 1Laboratory of Vascular Biology, Division of Physiology, Department of Medicine, Faculty of Science, University of Fribourg Fribourg, Switzerland.

Frontiers in Physiology
|February 1, 2012
PubMed

Insights

Global population aging accelerates, increasing cardiovascular disease challenges. This review explores the role of mTORC1-S6K1 signaling in cardiovascular aging, offering insights for healthy lifespan extension.

Area of Science:

  • Gerontology and Cardiovascular Science
  • Molecular Biology and Aging

Background:

  • Global population aging presents increasing challenges from age-associated diseases, particularly cardiovascular diseases.
  • The mechanisms of aging and cardiovascular dysfunction are not fully understood.
  • Mammalian target of rapamycin complex 1 (mTORC1) and S6K1 signaling are implicated in lifespan regulation and age-related diseases like diabetes and cancer.

Purpose of the Study:

  • To review recent advances in understanding the role of mTORC1-S6K1 signaling in cardiovascular aging.
  • To discuss the potential of targeting mTORC1-S6K1 for anti-aging and cardiovascular health.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Focuses on summarizing recent experimental findings and evidence.
  • Discusses the controversial and largely unknown role of mTORC1-S6K1 in cardiovascular aging.

Main Results:

  • Substantial evidence links mTORC1-S6K1 signaling to lifespan regulation and other age-related diseases.
  • The specific role of mTORC1-S6K1 in age-related cardiovascular diseases remains largely unknown and debated.
  • Recent advances are beginning to shed light on this complex relationship.

Conclusions:

  • Targeting mTORC1-S6K1 signaling presents a potential therapeutic strategy for promoting healthy lifespan and combating cardiovascular aging.
  • Further research is needed to clarify the precise mechanisms and therapeutic applications of modulating mTORC1-S6K1 in cardiovascular aging.

Keywords:
S6K1agingeNOSendothelial senescencemTORoxidative stressrapamycinresveratrol

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...